131 related articles for article (PubMed ID: 7904188)
1. Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury.
Hudson N; Murray FE; Cole AT; Turnbull GM; Lettis S; Hawkey CJ
Aliment Pharmacol Ther; 1993 Oct; 7(5):515-21. PubMed ID: 7904188
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin.
Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ
Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156
[TBL] [Abstract][Full Text] [Related]
4. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
[TBL] [Abstract][Full Text] [Related]
5. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
Ciociola AA; Webb DD; Heath A; Walsh JH
Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287
[TBL] [Abstract][Full Text] [Related]
6. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
Scheen AJ
Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
[TBL] [Abstract][Full Text] [Related]
7. Gastric persorption of bismuth from ranitidine bismuth citrate.
Fraser AG; Lewin JF; Pounder RE
Aliment Pharmacol Ther; 1995 Aug; 9(4):447-50. PubMed ID: 8527622
[TBL] [Abstract][Full Text] [Related]
8. Ranitidine bismuth citrate and ranitidine do not affect gastric emptying of a radio-labelled liquid meal.
Parikh R; Sweetland J; Forster ER; Bedding AW; Farr SJ; Smith JT
Br J Clin Pharmacol; 1994 Dec; 38(6):577-80. PubMed ID: 7888296
[TBL] [Abstract][Full Text] [Related]
9. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine.
Daneshmend TK; Prichard PJ; Bhaskar NK; Millns PJ; Hawkey CJ
Gastroenterology; 1989 Oct; 97(4):944-9. PubMed ID: 2570732
[TBL] [Abstract][Full Text] [Related]
10. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer.
Bardhan KD; Dekkers CP; Lam SK; Nowak A; Schaffalitzky de Muckadell OB; Schutze K; Tildesley G; Kler L; Forster JK; Lacey LF
Aliment Pharmacol Ther; 1995 Oct; 9(5):497-506. PubMed ID: 8580269
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
Lacey LF; Frazer NM; Keene ON; Smith JT
Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
[TBL] [Abstract][Full Text] [Related]
12. Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori.
Dixon JS; Pipkin GA; Mills JG; Wood JR
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():47-58. PubMed ID: 9440055
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of aspirin-induced gastric mucosal bleeding with ranitidine.
Hawkey CJ; Somerville KW; Marshall S
Aliment Pharmacol Ther; 1988 Jun; 2(3):245-52. PubMed ID: 2979248
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
[TBL] [Abstract][Full Text] [Related]
15. Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens.
Fraser AG; Lam WM; Luk YW; Sercombe J; Sawyerr AM; Hudson M; Samloff IM; Pounder RE
Gut; 1993 Mar; 34(3):338-42. PubMed ID: 8472980
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
McColm AA; McLaren A; Klinkert G; Francis MR; Connolly PC; Grinham CJ; Campbell CJ; Selway S; Williamson R
Aliment Pharmacol Ther; 1996 Jun; 10(3):241-50. PubMed ID: 8791946
[TBL] [Abstract][Full Text] [Related]
17. [Ranitidine protects the human stomach and duodenal mucosa against low-dose acetylsalicylic acid].
Müller P; Damman HG; Marinis E; Simon B
Z Gastroenterol; 1989 Dec; 27(12):722-4. PubMed ID: 2697116
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine bismuth citrate therapy.
Harris A; Misiewicz JJ
Aliment Pharmacol Ther; 1996 Dec; 10(6):1035. PubMed ID: 8971307
[No Abstract] [Full Text] [Related]
19. The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori.
Wyeth JW; Pounder RE; Duggan AE; O'Morain CA; Schaufelberger HD; De Koster EH; Rauws EA; Bardhan KD; Gilvarry J; Buckley MJ; Gummett PA; Logan RP
Aliment Pharmacol Ther; 1996 Aug; 10(4):623-30. PubMed ID: 8853768
[TBL] [Abstract][Full Text] [Related]
20. The effect of GR122311X, a bismuth compound with H2-antagonist activity, on 24-hour intragastric acidity.
Prewett EJ; Nwokolo CU; Hudson M; Sawyerr AM; Fraser A; Pounder RE
Aliment Pharmacol Ther; 1991 Oct; 5(5):481-90. PubMed ID: 1686562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
